Literature DB >> 29303149

Assessment and management of dry eye disease.

R J Buckley1.   

Abstract

The topic of the 1984 Cambridge Ophthalmological Symposium was 'The Dry Eye'; it was chaired by my colleague and mentor Mr Peter Wright. In the 33 years that have passed since then we have learned a great deal more about this condition. This short paper sets out to review some of the more recent developments.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29303149      PMCID： PMC5811740          DOI： 10.1038/eye.2017.289

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


  23 in total

Review 1.  Grading of corneal and conjunctival staining in the context of other dry eye tests.

Authors:  Anthony J Bron; Victoria E Evans; Janine A Smith
Journal:  Cornea       Date:  2003-10       Impact factor: 2.651

2.  Age- and gender-related tear function changes in normal population.

Authors:  M Ozdemir; H Temizdemir
Journal:  Eye (Lond)       Date:  2009-02-20       Impact factor: 3.775

Review 3.  [Experiences with a centralised national service for autologous serum eyedrops in England].

Authors:  S Maclennan; D Hartwig; G Geerling
Journal:  Ophthalmologe       Date:  2008-07       Impact factor: 1.059

Review 4.  TFOS DEWS II Introduction.

Authors:  J Daniel Nelson; Jennifer P Craig; Esen K Akpek; Dimitri T Azar; Carlos Belmonte; Anthony J Bron; Janine A Clayton; Murat Dogru; Harminder S Dua; Gary N Foulks; José A P Gomes; Katherine M Hammitt; Juha Holopainen; Lyndon Jones; Choun-Ki Joo; Zuguo Liu; Jason J Nichols; Kelly K Nichols; Gary D Novack; Virender Sangwan; Fiona Stapleton; Alan Tomlinson; Kazuo Tsubota; Mark D P Willcox; James S Wolffsohn; David A Sullivan
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

5.  Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study.

Authors:  Michael A Lemp; Leslie A Crews; Anthony J Bron; Gary N Foulks; Benjamin D Sullivan
Journal:  Cornea       Date:  2012-05       Impact factor: 2.651

6.  Estimating basal tear osmolarity in normal and dry eye subjects.

Authors:  Catherine Willshire; Roger J Buckley; Anthony J Bron
Journal:  Cont Lens Anterior Eye       Date:  2017-09-22       Impact factor: 3.077

7.  Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women.

Authors:  Biljana Miljanović; Komal A Trivedi; M Reza Dana; Jeffery P Gilbard; Julie E Buring; Debra A Schaumberg
Journal:  Am J Clin Nutr       Date:  2005-10       Impact factor: 7.045

8.  Effectiveness of dry eye therapy under conditions of environmental stress.

Authors:  Alan Tomlinson; Louise C Madden; Peter A Simmons
Journal:  Curr Eye Res       Date:  2013-01-07       Impact factor: 2.424

9.  A randomized study of the efficacy and safety of 0.1% cyclosporine A cationic emulsion in treatment of moderate to severe dry eye.

Authors:  Christophe Baudouin; Francisco C Figueiredo; Elisabeth M Messmer; Dahlia Ismail; Mourad Amrane; Jean-Sébastien Garrigue; Stefano Bonini; Andrea Leonardi
Journal:  Eur J Ophthalmol       Date:  2017-03-21       Impact factor: 2.597

10.  A randomized, double-masked, parallel-group, comparative study to evaluate the clinical efficacy and safety of 1% azithromycin-0.1% dexamethasone combination compared to 1% azithromycin alone, 0.1% dexamethasone alone, and vehicle in the treatment of subjects with blepharitis.

Authors:  Kamran Hosseini; Richard L Lindstrom; Gary Foulks; Kelly K Nichols
Journal:  Clin Ophthalmol       Date:  2016-08-10
View more
  7 in total

Review 1.  Selective Pharmacologic Therapies for Dry Eye Disease Treatment: Efficacy, Tolerability, and Safety Data Review from Preclinical Studies and Pivotal Trials.

Authors:  Bridgitte Shen Lee; Melissa Toyos; Paul Karpecki; Jessica Schiffbauer; John Sheppard
Journal:  Ophthalmol Ther       Date:  2022-05-24

2.  Dry Eye Treatment with Topical Cyclosporine 0.1% in Chondroitin Sulfate Ophthalmic Emulsion.

Authors:  Cynthia Matossian; William Trattler; Jennifer Loh
Journal:  Clin Ophthalmol       Date:  2021-05-11

Review 3.  Trends in Dry Eye Disease Management Worldwide.

Authors:  Mohamed Mostafa Hantera
Journal:  Clin Ophthalmol       Date:  2021-01-14

4.  Analysis of Conjunctival Sac Microbiome in Dry Eye Patients With and Without Sjögren's Syndrome.

Authors:  Hang Song; Kang Xiao; Zhengyu Chen; Qin Long
Journal:  Front Med (Lausanne)       Date:  2022-03-08

5.  Comparative antioxidant activity of various ophthalmic product types for artificial tears under different experimental conditions.

Authors:  Sanda Jurja; Ticuta Negreanu-Pirjol; Monica Vasile; Mihaela Hincu; Radu Ciuluvica; Bogdan-Stefan Negreanu-Pirjol
Journal:  Exp Ther Med       Date:  2022-03-15       Impact factor: 2.447

6.  Anxiety and depression in inflammatory eye disease: exploring the potential impact of topical treatment frequency as a putative psychometric item.

Authors:  Georgios Vakros; Paolo Scollo; James Hodson; Philip I Murray; Saaeha Rauz
Journal:  BMJ Open Ophthalmol       Date:  2021-07-06

Review 7.  Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care.

Authors:  Brent Bluett; Alexander Y Pantelyat; Irene Litvan; Farwa Ali; Diana Apetauerova; Danny Bega; Lisa Bloom; James Bower; Adam L Boxer; Marian L Dale; Rohit Dhall; Antoine Duquette; Hubert H Fernandez; Jori E Fleisher; Murray Grossman; Michael Howell; Diana R Kerwin; Julie Leegwater-Kim; Christiane Lepage; Peter Alexander Ljubenkov; Martina Mancini; Nikolaus R McFarland; Paolo Moretti; Erica Myrick; Pritika Patel; Laura S Plummer; Federico Rodriguez-Porcel; Julio Rojas; Christos Sidiropoulos; Miriam Sklerov; Leonard L Sokol; Paul J Tuite; Lawren VandeVrede; Jennifer Wilhelm; Anne-Marie A Wills; Tao Xie; Lawrence I Golbe
Journal:  Front Neurol       Date:  2021-07-01       Impact factor: 4.003
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.